Company intelligence / Profile preview
Ceria Therapeutics, Inc.
Tucson, Arizona, United Statesceriatherapeutics.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Ceria Therapeutics is a preclinical-stage biotech company developing first-in-class drug products that target the root cause of inflammation in acute and chronic conditions. Their lead programs use nanoparticle-based delivery of miR146a to modulate inflammatory pathways. The company has received multiple SBIR grants and a Department of Defense contract to advance its pipeline toward IND-enabling studies for indications such as acute lung injury and non-healing diabetic foot ulcers. No clinical results are available yet as all programs remain preclinical.
- Therapeutic areas
- PulmonologyEndocrinologyDermatologyGastroenterologyNephrologyInfectious Diseases
- Modalities
- microRNA therapeutics (miRNA)Nanoparticle drug delivery
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Request access →03
Partnerships
Collaborations with University of Colorado Anschutz Medical Campus and University of Arizona Medical CenterU.S. Department of Defense contract for ALI program development
Beyond the preview
Go deeper on Ceria Therapeutics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ceria Therapeutics, Inc..